共 5 条
[1]
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study
[J].
JOURNAL OF HEPATOLOGY,
2009, 50 (06)
:1084-1092
Moucari, Rami
;
Korevaar, Anneke
;
Lada, Olivier
;
Martinot-Peignoux, Michelle
;
Boyer, Nathalie
;
Mackiewicz, Vincent
;
Dauvergne, Agnes
;
Cardoso, Ana C.
;
Asselah, Tarik
;
Nicolas-Chanoine, Marie-Helene
;
Vidaud, Michel
;
Valla, Dominique
;
Bedossa, Pierre
;
Marcellin, Patrick
.
[2]
Early Serum HBsAg Drop: A Strong Predictor of Sustained Virological Response to Pegylated Interferon Alfa-2a in HBeAg-Negative Patients
[J].
HEPATOLOGY,
2009, 49 (04)
:1151-1157
Moucari, Rami
;
Mackiewicz, Vincent
;
Lada, Olivier
;
Ripault, Marie-Pierre
;
Castelnau, Corinne
;
Martinot-Peignoux, Michelle
;
Dauvergne, Agnes
;
Asselah, Tarik
;
Boyer, Nathalie
;
Bedossa, Pierre
;
Valla, Dominique
;
Vidaud, Michel
;
Nicolas-Chanoine, Marie-Helene
;
Marcellin, Patrick
.
[3]
103 VIROLOGICAL AND BIOCHEMICAL RESPONSE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B TREATED WITH PEGINTERFERON ALFA-2A (40KD) WITH OR WITHOUT LAMIVUDINE: RESULTS OF 4-YEAR FOLLOW-UP.[J].P. Marcellin;T. Piratvisuth;M. Brunetto;F. Bonino;G.K.K. Lau;P. Farci;C. Yurdaydin;J. Wu;M. Popescu.Journal of Hepatology.2008,
[4]
The role of the interferon regulatory factor (IRF) family in dendritic cell development and function.[J].Lucia Gabriele;Keiko Ozato.Cytokine and Growth Factor Reviews.2007, 5
[5]
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.[J].Harry LA Janssen;Monika van Zonneveld;Hakan Senturk;Stefan Zeuzem;Ulus S Akarca;Yilmaz Cakaloglu;Christopher Simon;Thomas MK So;Guido Gerken;Robert A de Man;Hubert GM Niesters;Pieter Zondervan;Bettina Hansen;Solko W Schalm.The Lancet.2005, 9454